Standout Papers

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial 2016 2026 2019 2022 307
  1. Topical tofacitinib for atopic dermatitis: a phase II a randomized trial (2016)
    Robert Bissonnette, Kim Papp et al. British Journal of Dermatology

Immediate Impact

2 from Science/Nature 96 standout
Sub-graph 1 of 21

Citing Papers

Atopic dermatitis
2025 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
4 intermediate papers

Works of C. Wang being referenced

Topical tofacitinib for atopic dermatitis: a phase II a randomized trial
2016 Standout
Phase 1 Dose-Escalation Study of CP-690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics
2008

Author Peers

Author Last Decade Papers Cites
C. Wang 180 45 142 257 177 15 517
Mark S. Fradin 128 35 302 174 28 10 565
TH. JOOST 96 26 155 278 115 15 528
Lillian Staub Nielsen 122 103 322 47 27 21 616
Alexander Marsland 365 36 286 229 52 29 616
Silke Frey 170 55 349 122 21 20 624
Quentin Simon 65 19 325 17 27 17 495
Anna Peroni 154 20 76 242 52 14 474
Tara M. Engeman 15 4 397 89 74 9 577
Véronique Bajzik 27 37 228 51 208 10 601
K Lorré 21 33 358 22 49 22 538

All Works

Loading papers...

Rankless by CCL
2026